These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7108208

  • 1. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S, Tsubura E.
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ, Fidler IJ.
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [Abstract] [Full Text] [Related]

  • 4. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S, Fidler IJ.
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S, Mutsuura S, Ogawara M, Tsubura E.
    J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
    [Abstract] [Full Text] [Related]

  • 7. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE, Talmadge JE, Fidler IJ.
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [Abstract] [Full Text] [Related]

  • 8. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ, Schroit AJ.
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [Abstract] [Full Text] [Related]

  • 9. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 10. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
    Fidler IJ, Raz A, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
    [Abstract] [Full Text] [Related]

  • 11. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
    Phillips NC, Moras ML, Chedid L, Lefrancier P, Bernard JM.
    Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
    [Abstract] [Full Text] [Related]

  • 12. Rat alveolar macrophages are susceptible to activation by free and liposome-encapsulated lymphokines.
    Sone S, Poste G, Fidler IJ.
    J Immunol; 1980 May; 124(5):2197-202. PubMed ID: 7365253
    [Abstract] [Full Text] [Related]

  • 13. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
    Saiki I, Sone S, Fogler WE, Kleinerman ES, Lopez-Berestein G, Fidler IJ.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
    [Abstract] [Full Text] [Related]

  • 14. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
    Phillips NC, Chedid L, Bernard JM, Level M, Lefrancier P.
    J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
    [Abstract] [Full Text] [Related]

  • 15. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
    [Abstract] [Full Text] [Related]

  • 16. In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin.
    Sone S, Moriguchi S, Shimizu E, Ogushi F, Tsubura E.
    Cancer Res; 1982 Jun; 42(6):2227-31. PubMed ID: 7074604
    [Abstract] [Full Text] [Related]

  • 17. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
    Poste G, Kirsh R, Fogler WE, Fidler IJ.
    Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
    Phillips NC, Tsao MS.
    Cancer Res; 1989 Feb 15; 49(4):936-9. PubMed ID: 2912563
    [Abstract] [Full Text] [Related]

  • 19. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul 15; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 20. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D, Jeannin JF, Martin F.
    C R Seances Acad Sci III; 1982 Nov 08; 295(8):485-8. PubMed ID: 6819063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.